Search - tctmd.com

Displaying 81 - 100 of 2466

Sort: Relevancy | Date

News Industry News TCT 2016

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

November 01, 2016

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

Presentation TCT 2016

Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations

Presenter: Neil E. Moat, John G. Webb, Philippe Généreux

October 31, 2016

Presentation TCT 2016

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

Presenter: Neil E. Moat, John G. Webb, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement

Presenter: Wojtek Wojakowski, Florian Deuschl

October 31, 2016

Presentation TCT 2016

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Neil E. Moat, John G. Webb, Marina Urena

October 31, 2016

Presentation TCT 2016

Grand Summary: TMVR Outcomes to Date Successes, Failures, and Implications

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben

October 31, 2016

Presentation TCT 2016

Cephea: Design Development Update

Presenter: Juan F. Granada

October 31, 2016

Presentation TCT 2016

St. Jude TMVR: Design Development Update

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Anson Cheung

October 31, 2016

Presentation TCT 2016

Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific

Presenter: Neil E. Moat, John G. Webb, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Direct Flow TMVR: Design Development Update

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Azeem Latib

October 31, 2016

Presentation TCT 2016

Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC

Presenter: Neil E. Moat, John G. Webb, Alexandra J. Lansky

October 31, 2016

Presentation TCT 2016

Valtech TMVR: Design Development Update

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

M-Dock: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Maurice Buchbinder

October 31, 2016

Presentation TCT 2016

Caisson: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Mathew Williams

October 31, 2016

Presentation TCT 2016

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Presenter: Neil E. Moat, John G. Webb, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

Sinomed: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Maurizio Taramasso

October 31, 2016

Presentation TCT 2016

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

Presenter: Neil E. Moat, John G. Webb, Stephen R. Ramee

October 31, 2016

Presentation TCT 2016

HighLife: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Ruediger S. Lange

October 31, 2016

Presentation TCT 2016

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Presenter: Neil E. Moat, John G. Webb, Pieter R. Stella

October 31, 2016

Advertisement

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Grand Summary: TMVR Outcomes to Date Successes, Failures, and Implications

Cephea: Design Development Update

St. Jude TMVR: Design Development Update

Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific

Direct Flow TMVR: Design Development Update

Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC

Valtech TMVR: Design Development Update

M-Dock: Design and Clinical Trial Updates

Caisson: Design and Clinical Trial Updates

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Sinomed: Design and Clinical Trial Updates

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

HighLife: Design and Clinical Trial Updates

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content